Ebola Q&A for Health Care Workers
Participants on the “NETEC Town Hall: Preparing Frontline Healthcare Workers for Ebola” webinar submitted questions to our subject matter experts. Many of the questions were answered during the event, however the remaining questions have been answered by our experts below. While many answers are universal, some responses are based on the practices within a particular institution that supports NETEC. If you have additional questions, please contact our support services group by filling out this form.
Q&As:
Laboratory
Contact your public health department to discuss your role. Size of your facility and location in relation to a Treatment Center may determine the testing that is requested. See the CDC’s link on testing that is anticipated for a VHF patient in each of the tiers: https://www.cdc.gov/viral-hemorrhagic-fevers/php/laboratories/specimen-collection.html.
The recommendation would be to clean and disinfect the instrumentation after each patient specimen.
The CDC does give recommendations on patient care management, however the ordering guidelines at your facility will be dependent on your care team and their protocols. Discuss with your care team the expectations for patient management in your facility. If blood cultures are expected, discuss with your lab and care team the risks involved in collection and how to safely mitigate those risks.
Testing on certain larger analyzers is possible, however it would be dependent on your facilities risk assessment. Looking at the workflow, any areas that may be aerosol generating, and the ability to decontaminate after a patient sample should all be taken in to consideration.
It is not required, however it is recommended to document every tube (including waste tubes) so that everything is accounted for and does not accidentally get mixed with other laboratory specimens.